Boundless Bio is a developer of novel cancer therapeutics intended to understand and treat intractable cancers. It offers cancer drugs and extrachromosomal DNA (ecDNA) that eliminate cancer cells' ability to employ ecDNA to survive, enabling healthcare professionals to treat most-difficult cancers.